A study co-led by UCLA Health Jonsson Comprehensive Cancer Center investigators found that combining the immunotherapy drug ...

It is an immunotherapy-based drug ... for the first-line treatment of primary advanced or recurrent endometrial cancer to improve survival. "With this FDA approval, Jemperli is now the only ...

I want to move to a hotter topic in endometrial cancer, and that's really around immunotherapy. You gave the invited discussant presentation at the Society of Gynecologic Oncology (SGO ...

If you have recurrent endometrial cancer, your doctor will talk to you about your treatment options, including radiation, chemotherapy, immunotherapy, or sometimes surgery. (Photo Credit ...

Immunotherapy drugs like dostarlimab have been used as a front-line treatment for some metastatic cancers, melanoma, and other cancer types. Dostarlimab was first approved for use in endometrial ...

and endometrial cancer" and can also be found in “cancers of the breast, prostate, bladder and thyroid.” The immunotherapy drug works by targeting cells with this mutation, as the ...

A study co-led by UCLA Health Jonsson Comprehensive Cancer Center investigators found that combining the immunotherapy drug dostarlimab with ...

About 16% of ovarian cancers and as much as 30% of endometrial cancers ... people are being diagnosed with cancer, Cercek said. The research also suggests that immunotherapy could possibly be ...

These immunotherapy drugs effectively remove the “brakes” that cancer cells place on the ... The drug is already approved for treating endometrial cancers with the same genetic mutation.